TRENDING :  Market Movers  |  Top 50   AAPL (-0.23%)    FB (-0.89%)    KO (-0.77%)    AMZN (-0.91%)    UGAZ (4.96%)    VXXB (-3.5%)    MGM (3.07%)    MDB (1.02%)    KRE (2.17%)    AMD (2.38%)    ABMD (1.19%)    AA (0.25%)    IVC (12.08%)    HTGM (2.18%)    GOOS (-2.76%)    GH (4.51%)    GEVO (1.66%)    FUV (-31.27%)    FCEL (12.84%)    DIS (1.75%)    DGAZ (-4.98%)    CRON (2.26%)    CRM (-0.27%)    CGC (3.13%)    CAT (2.7%)

 VNDA - Vanda Pharmaceuticals Inc.

$21.11 [0.99][4.93%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $52.00
Low $29.00
Average $42.75
Current $21.11

CompanyAnalyst NamePT ActionActionRatingTargetDate
JMP SecuritiesRaisesMaintainsStrong Buy$52.0012/06/18
Cantor FitzgeraldAnnouncesUpgradesStrong Buy$43.0012/04/18
*Last 90 days


No recommendations found.

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



3 Top Growth Stocks to Buy Right Now

What are the characteristics of great growth stocks They usually represent businesses selling great products or services that create undeniable value for customers Those could be the sleek electronics sold by Apple or even boring water heaters sold by A O Smith Believe

Here's Why Vanda Pharmaceuticals Gained as Much as 11.1% Today

What happened Shares of Vanda Pharmaceuticals NASDAQ VNDA rose over 11 today after the company reported fourth quarter and full year 2018 financial results The jump higher is welcomed by shareholders who have seen the stock plunge lower in recent weeks after the U S Food

Vanda Pharmaceuticals Inc (VNDA) Q4 2018 Earnings Conference Call Transcript

Vanda Pharmaceuticals Inc NASDAQ VNDA Image source The Motley Fool Q4 160 2018 Earnings Conference Call Feb 13 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared

Vanda Pharmaceuticals (VNDA) Tops Q4 Earnings and Revenue Estimates

Vanda Pharmaceuticals VNDA came out with quarterly earnings of 0 26 per share beating the Zacks Consensus Estimate of 0 13 per share This compares to loss of 0 04 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings

Here's Why Vanda Pharmaceuticals Is Sinking Today

What happened Shares of Vanda Pharmaceuticals NASDAQ VNDA fell more than 19 today after the company announced it was pursuing legal action against the U S Food and Drug Administration The regulator has placed a partial clinical hold on the company s drug candidate

Oversold Conditions For Vanda Pharmaceuticals (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on

VNDA Crosses Below Key Moving Average Level

In trading on Wednesday shares of Vanda Pharmaceuticals Inc Symbol VNDA crossed below their 200 day moving average of 21 50 changing hands as low as 20 21 per share Vanda Pharmaceuticals Inc shares are currently trading off about 18 3 on the day The chart below shows the one

Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN

Top Health Care Stocks Top Health Care Stocks JNJ 0 38 JNJ 0 38 PFE 0 17 PFE 0 17 ABT FlatABT Flat MRK 0 19 MRK 0 19 AMGN FlatAMGN Flat Health care stocks were flat to lower pre bell Wednesday Health care stocks were flat to lower pre bell Wednesday Stocks moving on